Skip to main content

Advertisement

Log in

Bioactive compound from Lagerstroemia speciosa: activating apoptotic machinery in pancreatic cancer cells

  • Original Article
  • Published:
3 Biotech Aims and scope Submit manuscript

Abstract

The study was aimed at the identification of a potential anti-cancer compound from the leaf extract of Lagerstroemia speciosa, against pancreatic cancer cells (PANC-1). Out of different extracts tested, methanolic extract showed significant cytotoxicity at an IC50 of 289.5 ± 0.03 µg/mL after 24 h (MTT assay). The safety of the extract was ascertained using normal pancreatic cells (hTERT-HPNE). Methanolic extract was able to induce apoptosis in 28.9 ± 0.01% of PANC-1 cells as determined by flow cytometry. RT-PCR analysis of PANC-1 cells also recorded an increase in the mRNA expression of pro-apoptotic genes i.e., Caspase-3 (12.82 folds), Rb (10 folds) and Bad (8.74 folds) after treatment. Expression of other pro-apoptotic genes such as Bax and TNF was also upregulated by 4.04 and 4.01 folds, respectively. However, the mRNA expression of anti-apoptotic genes, NF-κB, Cdk and Bcl-2 was found to be downregulated. The bioactive extract was then fractionated on preparative silica gel plates into 24 bands. Out of these, band fraction 9 exhibited significant cytotoxicity (IC50 219 ± 0.04 µg/mL) on the PANC-1 cells. The mass spectral (HPLC–MS) and FTIR analysis of the fraction indicated the bioactive compound to be a derivative of Diosgenin, which can be a possible candidate for cancer therapeutics in future.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8

Similar content being viewed by others

Availability of data and material

All the relevant data and material has been provided in the main manuscript. Some non-important data has also been provided in the Supplementary Data File.

Code availability

Not applicable.

References

Download references

Acknowledgements

Authors express their gratitude towards BIRAC, New Delhi, India, Fresenius Kabi Oncology Limited (FKOL), Baddi, Himachal Pradesh, India and BioNEST-Panjab University, Chandigarh, India, for providing the financial support.

Funding

This research work was funded by BIRAC, New Delhi, India, Fresenius Kabi Oncology Limited (FKOL), Baddi, Himachal Pradesh, India and BioNEST-Panjab University, Chandigarh, India.

Author information

Authors and Affiliations

Authors

Contributions

All the authors have equal contributions. They all have reviewed the progressive drafts and approved the final version of the manuscript.

Corresponding author

Correspondence to Rohit Sharma.

Ethics declarations

Conflict of interest

The authors declare no conflict of interest for the current research work. There is no conflict of interest with respect to the patent.

Ethics approval

Not applicable.

Consent to participate

Not applicable.

Consent for publication

All the authors have their consent for the publication of this manuscript.

Accession numbers

Lagerstroemia speciosa (L.) Pers. was identified and deposited at the Herbarium, Department of Botany, Panjab University, Chandigarh vide voucher specimen number: 21687.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (DOCX 67 KB)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Goyal, S., Sharma, M. & Sharma, R. Bioactive compound from Lagerstroemia speciosa: activating apoptotic machinery in pancreatic cancer cells. 3 Biotech 12, 96 (2022). https://doi.org/10.1007/s13205-022-03155-w

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s13205-022-03155-w

Keywords

Navigation